PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmjcredLink to Publisher's site
 
Br Med J (Clin Res Ed). 1984 January 14; 288(6411): 99–102.
PMCID: PMC1443966

Pigmentation and skin reaction to sun as risk factors for cutaneous melanoma: Western Canada Melanoma Study.

Abstract

Between 1 April 1979 and 31 March 1981, 904 residents of the four western provinces of Canada (population 6.5 million), were diagnosed as suffering from primary cutaneous malignant melanoma. Of 801 patients aged 20-79 years, 665 (83%) were interviewed along with control subjects chosen at random from the general population and matched for age, sex, and province. After exclusion of 70 subjects with lentigo maligna or acral lentiginous melanoma, comparisons of the 595 case-control pairs showed that light hair, skin, and eye colour, a history of heavy freckling in adolescence, and a tendency to burn readily and tan poorly in the sun were significant risk factors for melanoma. The strongest primary associations were with blond hair (relative risk 7.1 compared with black hair), light colour of unexposed skin (relative risk 2.4), and severe freckling (relative risk 2.1). These associations were independent of ethnic origin and of recorded amount of exposure to the sun and were somewhat stronger for superficial spreading than for nodular melanoma. This study is the largest and most detailed of an incident series of melanomas to be published to date. The results were consistent with other studies reporting associations between melanoma and poor tanning ability, a tendency to burn easily, and a history of sunburn and showed that light hair colour was the strongest risk factor for the disease.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (974K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Elwood JM, Lee JA. Trends in mortality from primary tumours of skin in Canada. Can Med Assoc J. 1974 Apr 20;110(8):913–915. [PMC free article] [PubMed]
  • Lee JA, Carter AP. Secular trends in mortality from malignant melanoma. J Natl Cancer Inst. 1970 Jul;45(1):91–97. [PubMed]
  • Holman CD, James IR, Gattey PH, Armstrong BK. An analysis of trends in mortality from malignant melanoma of the skin in Australia. Int J Cancer. 1980 Dec 15;26(6):703–709. [PubMed]
  • Swerdlow AJ. Incidence of malignant melanoma of the skin in England and Wales and its relationship to sunshine. Br Med J. 1979 Nov 24;2(6201):1324–1327. [PMC free article] [PubMed]
  • Jensen OM, Bolander AM. Trends in malignant melanoma of the skin. World Health Stat Q. 1980;33(1):2–26. [PubMed]
  • LANCASTER HO. Some geographical aspects of the mortality from melanoma in Europeans. Med J Aust. 1956 Jun 30;43(26):1082–1087. [PubMed]
  • Elwood JM, Lee JA, Walter SD, Mo T, Green AE. Relationship of melanoma and other skin cancer mortality to latitude and ultraviolet radiation in the United States and Canada. Int J Epidemiol. 1974 Dec;3(4):325–332. [PubMed]
  • Fears TR, Scotto J, Schneiderman MA. Skin cancer, melanoma, and sunlight. Am J Public Health. 1976 May;66(5):461–464. [PubMed]
  • Crombie IK. Variation of melanoma incidence with latitude in North America and Europe. Br J Cancer. 1979 Nov;40(5):774–781. [PubMed]
  • LANCASTER HO, NELSON J. Sunlight as a cause of melanoma; a clinical survey. Med J Aust. 1957 Apr 6;44(14):452–456. [PubMed]
  • PACK GT, DAVIS J, OPPENHEIM A. The relation of race and complexion to the incidence of moles and melanomas. Ann N Y Acad Sci. 1963 Feb 15;100:719–742. [PubMed]
  • Gellin GA, Kopf AW, Garfinkel L. Malignant melanoma. A controlled study of possibly associated factors. Arch Dermatol. 1969 Jan;99(1):43–48. [PubMed]
  • Adam SA, Sheaves JK, Wright NH, Mosser G, Harris RW, Vessey MP. A case-control study of the possible association between oral contraceptives and malignant melanoma. Br J Cancer. 1981 Jul;44(1):45–50. [PubMed]
  • Klepp O, Magnus K. Some environmental and bodily characteristics of melanoma patients. A case-control study. Int J Cancer. 1979 Apr 15;23(4):482–486. [PubMed]
  • MacKie RM, Aitchison T. Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in scotland. Br J Cancer. 1982 Dec;46(6):955–960. [PubMed]
  • McGovern VJ, Shaw HM, Milton GW, Farago GA. Is malignant melanoma arising in a Hutchinson's melanotic freckle a separate disease entity? Histopathology. 1980 May;4(3):235–242. [PubMed]
  • Clark WH, Jr, Mihm MC., Jr Lentigo maligna and lentigo-maligna melanoma. Am J Pathol. 1969 Apr;55(1):39–67. [PubMed]
  • Crombie IK. Racial differences in melanoma incidence. Br J Cancer. 1979 Aug;40(2):185–193. [PubMed]
  • Nicholls EM. Genetic susceptibility and somatic mutation in the production of freckles, birthmarks and moles. Lancet. 1968 Jan 13;1(7533):71–73. [PubMed]
  • Mishima Y. Melanocytic and nevocytic malignant melanomas. Cellular and subcellular differentiation. Cancer. 1967 May;20(5):632–649. [PubMed]
  • Moles and malignant melanoma: terminology and CLASSIFICATION. Med J Aust. 1967 Jan 21;1(3):123–125. [PubMed]
  • Beitner H, Ringborg U, Wennersten G, Lagerlöf B. Further evidence for increased light sensitivity in patients with malignant melanoma. Br J Dermatol. 1981 Mar;104(3):289–294. [PubMed]

Articles from British Medical Journal (Clinical Research Ed.) are provided here courtesy of BMJ Publishing Group